Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. clinical trials
Acquired by China Resources Pharmaceutical Group Limited, Mar 27, 2025 · source ↗
The registry lists 1 studies whose lead sponsor is Jiangsu Tasly Diyi Pharmaceutical Co., Ltd.. 1 are recruiting or about to start. Per ClinicalTrials.gov, last updated May 8, 2024.
Before and after it joined China Resources Pharmaceutical Group Limited
- First submitted before Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. became part of China Resources Pharmaceutical Group Limited
- 1
- First submitted after Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. became part of China Resources Pharmaceutical Group Limited
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Jiangsu Tasly Diyi Pharmaceutical Co., Ltd.1 study
Something wrong with this grouping? Tell us on the China Resources Pharmaceutical Group Limited page.
Studies
Recruiting first, then most recently updated. Showing 1 of 1. All China Resources Pharmaceutical Group Limited studies →
- A Study to Evaluate the Efficacy and Safety of TSL-1502 Capsules in Breast Cancer Patients With Germline BRCA MutationsRecruitingNCT05420779Phase 2
Sponsor listed in the registry: Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. · First submitted before Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. became part of China Resources Pharmaceutical Group Limited